Cleared Traditional

K943005 - CREATININE QVET

K943005 is an FDA 510(k) clearance for CREATININE QVET, manufactured by Prisma Systems. The device is a Class 2 Chemistry device with product code CGX cleared through the Traditional 510(k) pathway after a 152-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1994
Decision
152d
Days
Class 2
Risk

K943005 is an FDA 510(k) clearance for the CREATININE QVET. Classified as Alkaline Picrate, Colorimetry, Creatinine (product code CGX), Class II - Special Controls.

Submitted by Prisma Systems (Rome, US). The FDA issued a Cleared decision on November 22, 1994 after a review of 152 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Prisma Systems devices

FDA 510(k) Submission Details - K943005

510(k) Number K943005 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 1994
Decision Date November 22, 1994
Days to Decision 152 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 88d · This submission: 152d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGX Device Classification - Class 2, Special Controls

Product Code CGX Alkaline Picrate, Colorimetry, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGX Alkaline Picrate, Colorimetry, Creatinine

All 117
Devices cleared under the same product code (CGX) and FDA review panel - the closest regulatory comparables to K943005.
SIGMA DIAGNOSTICS CREATININE REAGENT KIT
K963534 · Sigma Diagnostics, Inc. · Sep 1996
STC DIAGNOSTICS AUTO-LYTE CREATININE ASSAY
K954266 · Solarcare Technologies Corp,Inc. · Oct 1995
ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES
K951595 · Roche Diagnostic Systems, Inc. · Sep 1995
CREATININE-PO REAGENT KIT
K943924 · Synermed, Inc. · Sep 1994
ROCHE REAGENT FOR CREATININE
K941837 · Roche Diagnostic Systems, Inc. · Aug 1994
KODAK EKTACHEM DT SLIDES (URCR)
K934071 · Eastman Kodak Company · Mar 1994